Introducing Dexmedetomidine (RTU)

DEX RTU SELL SHEET
Juno Pharmaceuticals Corp. is pleased to announce the launch of the:
Dexmedetomidine Hydrochloride Injection 4 mcg / mL (RTU) vial 
400 mcg / 100 mL & 200 mcg / 50 mL
.
Product is now available at wholesalers.   
By Dewan Tasinuzzaman • August 29, 2024
Juno - CPHI 2024
By Dewan Tasinuzzaman • August 21, 2024
New Product Launch: Norepinephrine
By Dewan Tasinuzzaman • August 21, 2024
New Product Launch: Eptifibatide
By Dewan Tasinuzzaman • January 11, 2024
Quality & Compliance Specialist
By Dewan Tasinuzzaman • October 19, 2023
Regulatory Affairs Project Manager 
By Dewan Tasinuzzaman • September 11, 2023
Quality & Compliance Associate
By Dewan Tasinuzzaman • May 15, 2023
Juno Pharmaceuticals est fier d'être partenaire avec Omega Laboratories
By Dewan Tasinuzzaman • May 15, 2023
Juno Pharmaceuticals is proud to acquire Omega Laboratories
By Dewan Tasinuzzaman • April 24, 2023
Juno Pharmaceuticals Canada & Rosemont Joint Partnership Announcement
By Dewan Tasinuzzaman • April 6, 2023
New Product Launch: Bortezomib